Rona Smith

Also affiliated with Cambridge University Hospitals NHS Foundation Trust, Cambridge School, Bridge University, Addenbrooke's Hospital, National Patient Safety Foundation

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial”.

Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial

Annals of the Rheumatic Diseases(2023)10.1136/ard-2022-223559

N/A

2.2DataRank · unranked

120 citations

Rachel Jones, Ulrich Specks, Simon Bond, Marianna Nodale, Reem Al-Jayyousi +38 more

Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis

Annals of the Rheumatic Diseases(2020)10.1136/annrheumdis-2019-216863

N/A

0DataRank · unranked

175 citations

Rachel Jones, Ulrich Specks, Simon Bond, Marianna Nodale, Reem Al-Jayyousi +41 more

Response to: ‘Correspondence on ‘Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis’’ by Parikh et al

Annals of the Rheumatic Diseases(2021)10.1136/annrheumdis-2020-219329

N/A

0DataRank · unranked

0 citations

Peter A. Merkel, David Jayne, Rona Smith

Risk Factors for Relapse in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Among Patients With Relapse After Induction of Remission With Rituximab

Arthritis & Rheumatology(2025)10.1002/art.70025

N/A

0DataRank · unranked

1 citations

Joshua F. Baker, Thomas R. Riley, Ian Green, Rennie L. Rhee, Carol A. McAlear +6 more